Home The Word Brain My Amedeo FAQ Privacy About   

2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Free Subscription

Articles published in Virology

Retrieve available abstracts of 56 articles:
HTML format

Single Articles

    July 2024
  1. GILLOT C, Tre-Hardy M, Cupaiolo R, Blairon L, et al
    Assessment of the neutralizing antibody response in Omicron breakthrough cases in healthcare workers who received the homologous booster of Moderna mRNA-1273.
    Virology. 2024;595:110082.
    PubMed     Abstract available

    June 2024
  2. ZHANG B, Li S, Zhou J, Wang W, et al
    A novel virus-like particles vaccine induces broad immune protective against deltacoronavirus in piglets.
    Virology. 2024;597:110150.
    PubMed     Abstract available

  3. ABDEL-MONEIM AS, Murovska M, Soderlund-Venermo M, Vakharia VN, et al
    WSV2023 - The second meeting of the world society for virology: One health - One world - One virology.
    Virology. 2024;594:110049.
    PubMed     Abstract available

  4. HE X, Jiang N, Li Y
    Saccharomyces cerevisiae cells that display norovirus P induce both systemic and mucosal neutralizing antibodies.
    Virology. 2024;594:110034.
    PubMed     Abstract available

  5. GE P, Ross TM
    COBRA HA and NA vaccination elicits long-live protective immune responses against pre-pandemic H2, H5, and H7 influenza virus subtypes.
    Virology. 2024;597:110119.
    PubMed     Abstract available

    May 2024
  6. TIAN Y, Deng Z, Chuai Z, Li C, et al
    A combination influenza mRNA vaccine candidate provided broad protection against diverse influenza virus challenge.
    Virology. 2024;596:110125.
    PubMed     Abstract available

  7. BROGAARD L, Heegaard PMH, Larsen LE, Skovgaard K, et al
    Pulmonary MicroRNA expression after heterologous challenge with swine influenza A virus (H1N2) in immunized and non-immunized pigs.
    Virology. 2024;596:110117.
    PubMed     Abstract available

  8. YANG D, Wang X, Yang X, Qi S, et al
    Construction and immune effect evaluation of the S protein heptad repeat-based nanoparticle vaccine against porcine epidemic diarrhea virus.
    Virology. 2024;596:110113.
    PubMed     Abstract available

  9. SHAO J, Liu W, Gao S, Chang H, et al
    A recombinant multi-epitope trivalent vaccine for foot-and-mouth disease virus serotype O in pigs.
    Virology. 2024;596:110103.
    PubMed     Abstract available

    April 2024
  10. MA X, Wang Q, Xu X, Zhang W, et al
    miR-214-PTEN pathway is a potential mechanism for stress-induced immunosuppression affecting chicken immune response to avian influenza virus vaccine.
    Virology. 2024;595:110094.
    PubMed     Abstract available

  11. KIM KH, Bhatnagar N, Subbiah J, Liu R, et al
    Cross-protection against influenza viruses by chimeric M2e-H3 stalk protein or multi-subtype neuraminidase plus M2e virus-like particle vaccine in ferrets.
    Virology. 2024;595:110097.
    PubMed     Abstract available

  12. ZHANG F, Chai Z, Wang X, Zhang Z, et al
    Monkeypox: Can we count on the current smallpox immunization?
    Virology. 2024;592:109994.
    PubMed     Abstract available

    March 2024
  13. AMOSOVA IV, Timoshicheva TA, Kadyrova RA, Zabrodskaya YA, et al
    The investigation of the dynamics of changes in neutralizing antibody titers against type 5 adenovirus in the context of vaccination against a new coronavirus infection.
    Virology. 2024;594:110051.
    PubMed     Abstract available

  14. ZHENG X, Yang R, Zhao Y, Zhang Y, et al
    Alum/CpG adjuvant promotes immunogenicity of inactivated SARS-CoV-2 Omicron vaccine through enhanced humoral and cellular immunity.
    Virology. 2024;594:110050.
    PubMed     Abstract available

  15. HUONG TN, Lee ZQ, Lai SK, Lee HY, et al
    Evidence that an interaction between the respiratory syncytial virus F and G proteins at the distal ends of virus filaments mediates efficient multiple cycle infection.
    Virology. 2024;591:109985.
    PubMed     Abstract available

    February 2024
  16. MA B, Tao M, Li Z, Zheng Q, et al
    Mucosal vaccines for viral diseases: Status and prospects.
    Virology. 2024;593:110026.
    PubMed     Abstract available

    December 2023
  17. FAZEL F, Matsuyama-Kato A, Alizadeh M, Boodhoo N, et al
    Efficacy and tolerability of an mRNA vaccine expressing gB and pp38 antigens of Marek's disease virus in chickens.
    Virology. 2023;590:109970.
    PubMed     Abstract available

  18. YU R, Zhang L, Zhou P, Zhang Z, et al
    Evaluation of the immunoprotective effects of porcine deltacoronavirus subunit vaccines.
    Virology. 2023;590:109955.
    PubMed     Abstract available

    October 2023
  19. LATIFI T, Jalilvand S, Golsaz-Shirazi F, Arashkia A, et al
    Characterization and immunogenicity of a novel chimeric hepatitis B core-virus like particles (cVLPs) carrying rotavirus VP8*protein in mice model.
    Virology. 2023;588:109903.
    PubMed     Abstract available

    August 2023
  20. GOSAVI M, Kulkarni-Munje A, Patil HP
    Dual pattern recognition receptor ligands CL401, CL413, and CL429 as adjuvants for inactivated chikungunya virus.
    Virology. 2023;585:82-90.
    PubMed     Abstract available

    June 2023
  21. SU R, Shi Z, Li E, Zhu M, et al
    A Trim-RBD-GEM vaccine candidate protects mice from SARS-CoV-2.
    Virology. 2023;585:145-154.
    PubMed     Abstract available

    May 2023
  22. CHENCHULA S, Amerneni KC, Ghanta MK, Padmavathi R, et al
    Clinical virology and effect of Covid-19 vaccination and monoclonal antibodies against highly infectious SARS- CoV-2 omicron sub variant BF.7 (BA. A systematic review.
    Virology. 2023;584:38-43.
    PubMed     Abstract available

  23. MIAO X, Zhang L, Zhou P, Zhang Z, et al
    Recombinant human adenovirus type 5 based vaccine candidates against GIIa- and GIIb-genotype porcine epidemic diarrhea virus induce robust humoral and cellular response in mice.
    Virology. 2023;584:9-23.
    PubMed     Abstract available

    March 2023
  24. ZHANG Z, Yao F, Lv J, Ding Y, et al
    Identification of B-cell epitopes on structural proteins VP1 and VP2 of Senecavirus A and development of a multi-epitope recombinant protein vaccine.
    Virology. 2023;582:48-56.
    PubMed     Abstract available

  25. MANU M, Singha Mahapatra C, Pachauri R, Ompreethi B, et al
    Evaluation of an alternative method for determination of Protective Dose(50) of Classical swine fever vaccines.
    Virology. 2023;581:139-144.
    PubMed     Abstract available

  26. ADAMS A, Hendrikse M, Rybicki EP, Hitzeroth II, et al
    Optimal size of DNA encapsidated by plant produced human papillomavirus pseudovirions.
    Virology. 2023;580:88-97.
    PubMed     Abstract available

    February 2023
  27. CHA SH, You SH, Lee MA, Baek JH, et al
    Application of codon pair deoptimization for ORF7-induced attenuation of type I porcine reproductive and respiratory syndrome virus without reduced immune responses.
    Virology. 2023;579:119-127.
    PubMed     Abstract available

  28. TANG H, Wang H, Yang L, Chen H, et al
    Immunogenicity analysis of the E. coli expressed structural protein VP1 of persistent infection foot-and-mouth disease virus.
    Virology. 2023;579:111-118.
    PubMed     Abstract available

  29. ZHANG C, Zhang Y, Li Y, Lu J, et al
    Exosome-based delivery of VP1 protein conferred enhanced resistance of mice to CVB3-induced viral myocarditis.
    Virology. 2023;579:46-53.
    PubMed     Abstract available

    January 2023
  30. JI C, Zhang Y, Feng Y, Zhang X, et al
    A polymerase mechanism-based strategy constructing attenuated clones of enterovirus for vaccine vector development.
    Virology. 2023;580:1-7.

  31. ZHENG C, Liang Z, Lin Q, Chen M, et al
    Pathology, viremia, apoptosis during MDV latency in vaccinated chickens.
    Virology. 2023;579:169-177.
    PubMed     Abstract available

    December 2022
  32. DEHGANI-MOBARAKI P, Wang C, Floridi A, Floridi E, et al
    Long-term persistence of IgG antibodies in recovered COVID-19 individuals at 18 months post-infection and the impact of two-dose BNT162b2 (Pfizer-BioNTech) mRNA vaccination on the antibody response: Analysis using fixed-effects linear regression model
    Virology. 2022;578:111-116.
    PubMed     Abstract available

    November 2022
  33. HU Z, Chen JP, Xu JC, Chen ZY, et al
    Corrigendum to "A two-dose optimum for recombinant S1 protein-based COVID-19 vaccination" [Virology 566 (2022) 56-59].
    Virology. 2022;578:22-23.

  34. SANTOS LA, Almeida F, Giria M, Trigueiro-Louro J, et al
    Adaptive evolution of PB1 from influenza A(H1N1)pdm09 virus towards an enhanced fitness.
    Virology. 2022;578:1-6.
    PubMed     Abstract available

    October 2022
  35. LAMICHHANE P, Schmidt ME, Terhuja M, Varga SM, et al
    A live single-cycle RSV vaccine expressing prefusion F protein.
    Virology. 2022;577:51-64.
    PubMed     Abstract available

  36. BRAKEL KA, Ma Y, Binjawadagi R, Harder O, et al
    Codon-optimization of the respiratory syncytial virus (RSV) G protein expressed in a vesicular stomatitis virus (VSV) vector improves immune responses in a cotton rat model.
    Virology. 2022;575:101-110.
    PubMed     Abstract available

    September 2022
  37. TANG CY, Boftsi M, Staudt L, McElroy JA, et al
    SARS-CoV-2 and influenza co-infection: A cross-sectional study in central Missouri during the 2021-2022 influenza season.
    Virology. 2022;576:105-110.
    PubMed     Abstract available

  38. WANG R, Huang X, Cao T, Sun C, et al
    Development of a thermostable SARS-CoV-2 variant-based bivalent protein vaccine with cross-neutralizing potency against Omicron subvariants.
    Virology. 2022;576:61-68.
    PubMed     Abstract available

    August 2022
  39. OLCZAK P, Wong M, Tsai HL, Wang H, et al
    Vaccination with human alphapapillomavirus-derived L2 multimer protects against human betapapillomavirus challenge, including in epidermodysplasia verruciformis model mice.
    Virology. 2022;575:63-73.
    PubMed     Abstract available

  40. KONG D, Wen Z, Su H, Ge J, et al
    Corrigendum to "Newcastle disease virus vectored Nipah encephalitis vaccines induce B and T cell responses in mice and long-lasting neutralizing antibodies in pigs" [Virology 432 (2012) 327-335].
    Virology. 2022;573:176-177.

    July 2022
  41. OH J, Subbiah J, Kim KH, Park BR, et al
    Impact of hemagglutination activity and M2e immunity on conferring protection against influenza viruses.
    Virology. 2022;574:37-46.
    PubMed     Abstract available

    June 2022
  42. LIM H, Kim SE, Lee YH, Hwang YH, et al
    Immunogenicity of candidate SARS-CoV-2 DNA vaccines based on the spike protein.
    Virology. 2022;573:118-123.
    PubMed     Abstract available

    May 2022
  43. KHAN K, Khan SA, Jalal K, Ul-Haq Z, et al
    Immunoinformatic approach for the construction of multi-epitopes vaccine against omicron COVID-19 variant.
    Virology. 2022;572:28-43.
    PubMed     Abstract available

    April 2022
  44. NGUYEN NH, Nguyen PBT, Nguyen TQ, Do DT, et al
    Genotypic diversity of CSFV field strains: A silent risk reduces vaccination efficacy of CSFV vaccines in Vietnam.
    Virology. 2022;571:39-45.
    PubMed     Abstract available

  45. MI T, Wang T, Xu H, Sun P, et al
    Kappa-RBD produced by glycoengineered Pichia pastoris elicited high neutralizing antibody titers against pseudoviruses of SARS-CoV-2 variants.
    Virology. 2022;569:56-63.
    PubMed     Abstract available

    February 2022
  46. CHEN X, Sun HY, Lee CY, Rostad CA, et al
    Functional antibody-dependent cell mediated cytotoxicity (ADCC) responses to vaccine and circulating influenza strains following vaccination.
    Virology. 2022;569:44-55.
    PubMed     Abstract available

    January 2022
  47. MATSUYAMA-KATO A, Iseki H, Boodhoo N, Bavananthasivam J, et al
    Phenotypic characterization of gamma delta (gammadelta) T cells in chickens infected with or vaccinated against Marek's disease virus.
    Virology. 2022;568:115-125.
    PubMed     Abstract available

  48. ROSENGARTEN JF, Schatz S, Wolf T, Barbe S, et al
    Components of a HIV-1 vaccine mediate virus-like particle (VLP)-formation and display of envelope proteins exposing broadly neutralizing epitopes.
    Virology. 2022;568:41-48.
    PubMed     Abstract available

    December 2021
  49. PARK BR, Subbiah J, Kim KH, Kwon YM, et al
    Enhanced cross protection by hetero prime-boost vaccination with recombinant influenza viruses containing chimeric hemagglutinin-M2e epitopes.
    Virology. 2021;566:143-152.
    PubMed     Abstract available

  50. KORNUTA CA, Cheuquepan F, Bidart JE, Soria I, et al
    TLR activation, immune response and viral protection elicited in cattle by a commercial vaccine against Bovine Herpesvirus-1.
    Virology. 2021;566:98-105.
    PubMed     Abstract available

  51. HEINIMAKI S, Lampinen V, Tamminen K, Hankaniemi MM, et al
    Antigenicity and immunogenicity of HA2 and M2e influenza virus antigens conjugated to norovirus-like, VP1 capsid-based particles by the SpyTag/SpyCatcher technology.
    Virology. 2021;566:89-97.
    PubMed     Abstract available

  52. HU Z, Chen JP, Xu JC, Chen ZY, et al
    A two-dose optimum for recombinant S1 protein-based COVID-19 vaccination.
    Virology. 2021;566:56-59.
    PubMed     Abstract available

    November 2021
  53. SHI D, Fan B, Sun B, Zhou J, et al
    LDH nanoparticle adjuvant subunit vaccine induces an effective immune response for porcine epidemic diarrhea virus.
    Virology. 2021;565:58-64.
    PubMed     Abstract available

    October 2021
  54. AHMED SM, Nasr MA, Elshenawy SE, Hussein AE, et al
    BCG vaccination and the risk of COVID 19: A possible correlation.
    Virology. 2021;565:73-81.
    PubMed     Abstract available

    March 2021
  55. GAO W, Yue L, Yang T, Li H, et al
    A comparative study on biological characteristics of ten coxsackievirus A10 virus strains.
    Virology. 2021;555:1-9.
    PubMed     Abstract available

    November 2020
  56. POWELL JD, Abente EJ, Chang J, Souza CK, et al
    Characterization of contemporary 2010.1 H3N2 swine influenza A viruses circulating in United States pigs.
    Virology. 2020;553:94-101.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Vaccines is free of charge.